NYC Retina

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Glaucoma1 trial
• Macular degeneration1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Avisi Technologies Inc.1 trial
• EyePoint Pharmaceuticals, Inc.1 trial

Running trials

• Recruiting

  Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

  NCT07220876· Avisi Technologies Inc.· Source

  Contact: Katherine Lee

• Active, not recruiting

  A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

  NCT06683742· Phase 3· EyePoint Pharmaceuticals, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Glaucoma1 recruiting